KWM
TMO icon

Kingsview Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Kingsview Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.83M Buy
7,800
+1,743
+29% +$946K 0.05% 357
2025
Q4 		$3.51M Sell
6,057
-877
-13% -$496K 0.05% 351
2025
Q3 		$3.36M Sell
6,934
-16,361
-70% -$7.62M 0.05% 350
2025
Q2 		$9.45M Buy
23,295
+1,760
+8% +$736K 0.16% 122
2025
Q1 		$10.7M Buy
21,535
+1,238
+6% +$670K 0.2% 105
2024
Q4 		$10.6M Buy
20,297
+1,694
+9% +$931K 0.21% 94
2024
Q3 		$11.5M Sell
18,603
-62
-0.3% -$36.7K 0.24% 75
2024
Q2 		$10.3M Buy
18,665
+533
+3% +$305K 0.24% 79
2024
Q1 		$10.5M Buy
18,132
+1,128
+7% +$633K 0.26% 77
2023
Q4 		$9.03M Buy
17,004
+1,591
+10% +$770K 0.27% 82
2023
Q3 		$7.8M Buy
15,413
+440
+3% +$234K 0.28% 80
2023
Q2 		$7.81M Sell
14,973
-1,363
-8% -$736K 0.31% 74
2023
Q1 		$9.42M Buy
16,336
+3,975
+32% +$2.24M 0.4% 56
2022
Q4 		$6.81M Sell
12,361
-15,690
-56% -$8.31M 0.3% 86
2022
Q3 		$14.2M Buy
28,051
+10,843
+63% +$6.07M 0.67% 24
2022
Q2 		$9.35M Buy
17,208
+1,055
+7% +$581K 0.45% 46
2022
Q1 		$9.54M Sell
16,153
-1,117
-6% -$642K 0.42% 50
2021
Q4 		$11.5M Buy
17,270
+539
+3% +$337K 0.48% 39
2021
Q3 		$9.56M Buy
16,731
+662
+4% +$363K 0.45% 40
2021
Q2 		$8.19M Buy
16,069
+3,047
+23% +$1.44M 0.4% 45
2021
Q1 		$5.94M Buy
13,022
+5,068
+64% +$2.42M 0.34% 67
2020
Q4 		$3.71M Buy
7,954
+3,552
+81% +$1.67M 0.27% 90
2020
Q3 		$1.94M Buy
4,402
+10
+0.2% +$4.13K 0.17% 139
2020
Q2 		$1.59M Buy
4,392
+623
+17% +$209K 0.16% 144
2020
Q1 		$1.07M Buy
3,769
+912
+32% +$288K 0.14% 169
2019
Q4 		$928K Buy
2,857
+1,056
+59% +$320K 0.12% 203
2019
Q3 		$525K Sell
1,801
-246
-12% -$70.4K 0.08% 245
2019
Q2 		$601K Sell
2,047
-1,320
-39% -$364K 0.1% 217
2019
Q1 		$922K Sell
3,367
-70
-2% -$17.4K 0.14% 189
2018
Q4 		$769K Sell
3,437
-150
-4% -$35.2K 0.17% 164
2018
Q3 		$875K Buy
3,587
+559
+18% +$129K 0.18% 160
2018
Q2 		$627K Buy
3,028
+242
+9% +$51.4K 0.15% 167
2018
Q1 		$575K Buy
2,786
+671
+32% +$141K 0.14% 184
2017
Q4 		$402K Buy
2,115
+261
+14% +$50K 0.14% 199
2017
Q3 		$351K Buy
1,854
+24
+1% +$4.35K 0.15% 188
2017
Q2 		$319K Buy
1,830
+51
+3% +$8.57K 0.16% 174
2017
Q1 		$273K Buy
+1,779
New +$272K 0.16% 188

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Kingsview Wealth Management's TMO Position: Q1 2026 in Review

Kingsview Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 29% in Q1 2026, buying an estimated $946K and bringing the position to 7,800 shares worth $3.83M. The position accounts for 0.05% of the portfolio, ranked #357.

Kingsview Wealth Management first reported a position in TMO in Q1 2017 and has held it in 37 quarters since. The position peaked at $14.2M in Q3 2022. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Kingsview Wealth Management held 7,800 shares of Thermo Fisher Scientific worth $3.83M as of Q1 2026.
  • Kingsview Wealth Management bought 1,743 Thermo Fisher Scientific shares in Q1 2026, an estimated $946K.
  • Thermo Fisher Scientific made up 0.05% of Kingsview Wealth Management's portfolio in Q1 2026, its #357 holding.
  • Kingsview Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2017 and has held it in 37 quarters since.
  • Kingsview Wealth Management's Thermo Fisher Scientific position peaked at $14.2M in Q3 2022.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Kingsview Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.